Cargando…
The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials
Currently, there is no specific pharmaceutical agent for treating acute pancreatitis (AP). Somatostatin and its analogues have been used to prevent the autolysis of the pancreas in AP, however, their effectiveness has not been confirmed. This investigation aimed to examine the efficacy of ulinastati...
Autores principales: | Horváth, István László, Bunduc, Stefania, Fehérvári, Péter, Váncsa, Szilárd, Nagy, Rita, Garmaa, Gantsetseg, Kleiner, Dénes, Hegyi, Péter, Erőss, Bálint, Csupor, Dezső |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606296/ https://www.ncbi.nlm.nih.gov/pubmed/36289288 http://dx.doi.org/10.1038/s41598-022-22341-7 |
Ejemplares similares
-
No evidence for the benefit of PPIs in the treatment of acute pancreatitis: a systematic review and meta-analysis
por: Horváth, István László, et al.
Publicado: (2023) -
Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases
por: Váncsa, Szilárd, et al.
Publicado: (2021) -
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis
por: Dembrovszky, Fanni, et al.
Publicado: (2021) -
The negative impact of comorbidities on the disease course of COVID-19
por: Zádori, Noémi, et al.
Publicado: (2020) -
Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies
por: Mátis, Dóra, et al.
Publicado: (2023)